» Articles » PMID: 18592325

Surgical Resection Versus Radiofrequency Ablation in the Treatment of Small Unifocal Hepatocellular Carcinoma

Overview
Specialty Gastroenterology
Date 2008 Jul 2
PMID 18592325
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatocellular carcinoma (HCC) has a high worldwide prevalence and mortality. While surgical resection and transplantation offers curative potential, donor availability and patient liver status and comorbidities may disallow either. Interventional radiological techniques such as radiofrequency ablation (RFA) may offer acceptable overall and disease-free survival rates.

Materials And Methods: Sixty-eight cirrhotic patients matched for age, sex, tumor size, and Child-Pugh grade with small (1-5 cm) unifocal HCC were studied retrospectively to find determinants of overall and disease-free survival in those treated with surgical resection and RFA between 1991 and 2003.

Results: Multivariate analysis using Cox proportional regression modeling showed that overall survival was related to tumor recurrence (p = 0.010), tumor diameter (p = 0.002), and treatment modality (p = 0.014); overall p = 0.008. Recurrence was independently related to the use of RFA over surgery (p = 0.023) on multivariate analysis; overall p = 0.034.

Conclusion: Surgical resection offers longer disease-free survival and potentially longer overall survival than RFA in patients with small unifocal HCC.

Citing Articles

Benefits and drawbacks of radiofrequency ablation percutaneous or minimally invasive surgery for treating hepatocellular carcinoma.

Hsieh C, Peng C, Chen C, Liu C, Teng C, Liu Y World J Gastrointest Surg. 2024; 16(11):3400-3407.

PMID: 39649197 PMC: 11622093. DOI: 10.4240/wjgs.v16.i11.3400.


Machine Learning Model Based on Prognostic Nutritional Index for Predicting Long-Term Outcomes in Patients With HCC Undergoing Ablation.

Zhang N, Lin K, Qiao B, Yan L, Jin D, Yang D Cancer Med. 2024; 13(20):e70344.

PMID: 39440446 PMC: 11496905. DOI: 10.1002/cam4.70344.


Thermal ablation versus liver resection for hepatocellular carcinoma in patients with cirrhosis: a systematic review and meta-analysis of propensity-score matched studies.

Wei Q, Xiong S, Luo W, Liang M, Luo B Clin Exp Med. 2024; 24(1):32.

PMID: 38300338 PMC: 10834626. DOI: 10.1007/s10238-023-01285-w.


Rapid Quality Assessment of Nonrigid Image Registration Based on Supervised Learning.

Lee E, Plishker W, Hata N, Shyn P, Silverman S, Bhattacharyya S J Digit Imaging. 2021; 34(6):1376-1386.

PMID: 34647199 PMC: 8669090. DOI: 10.1007/s10278-021-00523-5.


Radiofrequency ablation vs. surgical resection for resectable hepatocellular carcinoma: A systematic review and meta-analysis.

Li J, Liu X, Cui H, Xie X Mol Clin Oncol. 2019; 12(1):15-22.

PMID: 31814972 PMC: 6888042. DOI: 10.3892/mco.2019.1941.


References
1.
Vivarelli M, Guglielmi A, Ruzzenente A, Cucchetti A, Bellusci R, Cordiano C . Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg. 2004; 240(1):102-7. PMC: 1356381. DOI: 10.1097/01.sla.0000129672.51886.44. View

2.
Garcea G, Lloyd T, Aylott C, Maddern G, Berry D . The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer. 2003; 39(15):2150-64. DOI: 10.1016/s0959-8049(03)00553-7. View

3.
Colombo M . Nonpercutaneous therapies of hepatocellular carcinoma. Hepatogastroenterology. 2001; 48(37):25-8. View

4.
Livraghi T, Goldberg S, Lazzaroni S, Meloni F, Solbiati L, Gazelle G . Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999; 210(3):655-61. DOI: 10.1148/radiology.210.3.r99fe40655. View

5.
Yoshizawa H . Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology. 2002; 62 Suppl 1:8-17. DOI: 10.1159/000048270. View